Skip to main content
TipRanks
Go Ultimate75% OFF

Ildong Pharmaceutical Co., Ltd. (249420) Stock Statistics & Valuation Metrics

Total Valuation

Ildong Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 388.61B. The enterprise value is KRW 499.19B.

Market Cap
KRW 388.61B
Enterprise Value
KRW 499.19B

Share Statistics

Ildong Pharmaceutical Co., Ltd. has 31,638,252 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
31,638,252
Owned by Insiders
―
Owned by Institutions
4.54%

Financial Efficiency

Ildong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 2.79%.

Return on Equity (ROE)
0.11
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
2.79%
Return on Capital Employed (ROCE)
0.05
Revenue Per Employee
513.53M
Profits Per Employee
25.06M
Employee Count
1,104
Asset Turnover
0.99
Inventory Turnover
3.50

Valuation Ratios

The current PE Ratio of Ildong Pharmaceutical Co., Ltd. is 21.92. Ildong Pharmaceutical Co., Ltd.’s PEG ratio is -0.52.

PE Ratio
21.92
PS Ratio
0.64
PB Ratio
1.48
Price to FCF
15.97
Price to Operating Cash Flow
10.74
PEG Ratio
-0.52

Income Statement

In the last 12 months, Ildong Pharmaceutical Co., Ltd. had revenue of 566.93B and earned 27.66B in profits. Earnings per share was 942.08.

Revenue
566.93B
Gross Profit
214.76B
Operating Income
17.32B
Pretax Income
31.80B
Net Income
27.66B
EBITDA
39.90B
Earnings Per Share (EPS)
942.08

Cash Flow

In the last 12 months, operating cash flow was 39.15B and capital expenditures -8.24B, giving a free cash flow of 30.91B billion.

Operating Cash Flow
39.15B
Free Cash Flow
30.91B
Free Cash Flow per Share
750.09

Dividends & Yields

Ildong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.63%

Dividend Per Share
―
Dividend Yield
1.63%
Payout Ratio
N/A
Free Cash Flow Yield
6.13%
Earnings Yield
4.33%

Stock Price Statistics

Beta
0.27
52-Week Price Change
-56.88%
50-Day Moving Average
13561.00
200-Day Moving Average
20439.14
Relative Strength Index (RSI)
42.58
Average Volume (3m)
296.27K

Important Dates

Ildong Pharmaceutical Co., Ltd. upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Ildong Pharmaceutical Co., Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 61.00%

Current Ratio
0.96
Quick Ratio
0.53
Debt to Market Cap
0.10
Net Debt to EBITDA
2.14
Interest Coverage Ratio
1.42

Taxes

In the past 12 months, Ildong Pharmaceutical Co., Ltd. has paid 8.08B in taxes.

Income Tax
8.08B
Effective Tax Rate
0.25

Enterprise Valuation

Ildong Pharmaceutical Co., Ltd. EV to EBITDA ratio is -13.54, with an EV/FCF ratio of 20.05.

EV to Sales
0.81
EV to EBITDA
-13.54
EV to Free Cash Flow
20.05
EV to Operating Cash Flow
13.43

Balance Sheet

Ildong Pharmaceutical Co., Ltd. has KRW 70.38B in cash and marketable securities with KRW 134.36B in debt, giving a net cash position of -KRW 63.98B billion.

Cash & Marketable Securities
KRW 70.38B
Total Debt
KRW 134.36B
Net Cash
-KRW 63.98B
Net Cash Per Share
-KRW 2,022.22
Tangible Book Value Per Share
KRW 0.00

Margins

Gross margin is 28.08%, with operating margin of 4.41%, and net profit margin of 2.86%.

Gross Margin
28.08%
Operating Margin
4.41%
Pretax Margin
2.75%
Net Profit Margin
2.86%
EBITDA Margin
-5.98%
EBIT Margin
-8.76%

Analyst Forecast

The average price target for Ildong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
2.12%
EPS Growth Forecast
-44.69%

Scores

Smart Score
―
AI Score
57